These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17171818)

  • 1. DNA repair by ERCC1 in non-small-cell lung cancer.
    Wilcox JE
    N Engl J Med; 2006 Dec; 355(24):2590; author reply 2591. PubMed ID: 17171818
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA repair by ERCC1 in non-small-cell lung cancer.
    Cecere F; Bria E; Rosell R
    N Engl J Med; 2006 Dec; 355(24):2590-1; author reply 2591. PubMed ID: 17167144
    [No Abstract]   [Full Text] [Related]  

  • 3. ERCC1 measurements in clinical oncology.
    Reed E
    N Engl J Med; 2006 Sep; 355(10):1054-5. PubMed ID: 16957152
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA repair by ERCC1 in non-small-cell lung cancer.
    Grenader T; Shavit L
    N Engl J Med; 2006 Dec; 355(24):2591; author reply 2591. PubMed ID: 17167936
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histoculture drug response assay guided adjuvant chemotherapy in patients with ERCC1-positive non-small cell lung cancer].
    Hirai Y; Yoshimasu T; Oura S; Tamaki T; Ota F; Nakamura R; Shimizu Y; Naito K; Ota M; Miyasaka M; Okamura Y; Nakamura Y; Yasuoka H; Kodama R
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):611-4. PubMed ID: 19381033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ERCC1 expression and outcomes of neo-adjuvant chemotherapy in elderly patients with non-small cell lung cancer].
    Li GF; Deng SJ; Weng WW; Guo G; Chen N
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2131-3. PubMed ID: 20855270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
    Olaussen KA; Dunant A; Fouret P; Brambilla E; André F; Haddad V; Taranchon E; Filipits M; Pirker R; Popper HH; Stahel R; Sabatier L; Pignon JP; Tursz T; Le Chevalier T; Soria JC;
    N Engl J Med; 2006 Sep; 355(10):983-91. PubMed ID: 16957145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.
    Olaussen KA; Mountzios G; Soria JC
    Curr Opin Pulm Med; 2007 Jul; 13(4):284-9. PubMed ID: 17534174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for excision repair cross-complementing 1 in patients with non-small-cell lung cancer for chemotherapy response.
    Felip E; Rosell R
    Expert Rev Mol Diagn; 2007 May; 7(3):261-8. PubMed ID: 17489733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between expression of excision repair cross-complementing 1 and cisplatin sensitivity in non-small cell lung cancer].
    Han XP; Zhang X
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2115-8. PubMed ID: 21029626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
    Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
    Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy].
    Moldvay J; Pápay J; Puskás R; Furák J; Losonczy G; Matolcsy A
    Magy Onkol; 2011 Jun; 55(2):105-9. PubMed ID: 21655476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for lung cancer.
    Ikhlaque N; Baumann MA
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy for lung cancer.
    Feliu J; Espinosa E; Sánchez JJ
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088319
    [No Abstract]   [Full Text] [Related]  

  • 17. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for lung cancer.
    Sauter C
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088320
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy for lung cancer.
    Morgan GW
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088321
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy for lung cancer.
    Büyükçelik A; Utkan G; Yalçin B
    N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15088318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.